SG10201703022SA - Method of prognosis and stratification of ovarian cancer - Google Patents
Method of prognosis and stratification of ovarian cancerInfo
- Publication number
- SG10201703022SA SG10201703022SA SG10201703022SA SG10201703022SA SG10201703022SA SG 10201703022S A SG10201703022S A SG 10201703022SA SG 10201703022S A SG10201703022S A SG 10201703022SA SG 10201703022S A SG10201703022S A SG 10201703022SA SG 10201703022S A SG10201703022S A SG 10201703022SA
- Authority
- SG
- Singapore
- Prior art keywords
- stratification
- prognosis
- ovarian cancer
- ovarian
- cancer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
- C12N2310/141—MicroRNAs, miRNAs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/10—Applications; Uses in screening processes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Plant Pathology (AREA)
- Hospice & Palliative Care (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SG2012076915 | 2012-10-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201703022SA true SG10201703022SA (en) | 2017-06-29 |
Family
ID=54141527
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201502778TA SG11201502778TA (en) | 2012-10-12 | 2013-10-11 | Method of prognosis and stratification of ovarian cancer |
| SG10201703022SA SG10201703022SA (en) | 2012-10-12 | 2013-10-11 | Method of prognosis and stratification of ovarian cancer |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201502778TA SG11201502778TA (en) | 2012-10-12 | 2013-10-11 | Method of prognosis and stratification of ovarian cancer |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20150267259A1 (en) |
| EP (1) | EP2906724A4 (en) |
| CN (1) | CN104854247A (en) |
| SG (2) | SG11201502778TA (en) |
| WO (1) | WO2014058394A1 (en) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9953417B2 (en) * | 2013-10-04 | 2018-04-24 | The University Of Manchester | Biomarker method |
| CN108091398B (en) * | 2016-11-21 | 2022-03-04 | 医渡云（北京）技术有限公司 | Patient grouping method and device |
| CN107050469B (en) * | 2017-01-18 | 2019-07-30 | 中国科学院昆明动物研究所 | The purposes of people's NCAPH gene |
| CN108229099B (en) * | 2017-12-29 | 2021-01-05 | 北京科迅生物技术有限公司 | Data processing method, data processing device, storage medium and processor |
| CN108470111B (en) * | 2018-05-09 | 2022-01-18 | 中国科学院昆明动物研究所 | Stomach cancer personalized prognosis evaluation method based on polygene expression profile |
| CN108647493B (en) * | 2018-05-09 | 2022-01-18 | 中国科学院昆明动物研究所 | Individualized prognosis evaluation method for renal clear cell carcinoma |
| US20210363590A1 (en) * | 2018-05-21 | 2021-11-25 | Nanostring Technologies, Inc. | Molecular gene signatures and methods of using same |
| CN113316823A (en) * | 2018-09-29 | 2021-08-27 | 豪夫迈·罗氏有限公司 | Clinical predictor based on multi-modal machine learning |
| GB201902653D0 (en) * | 2019-02-27 | 2019-04-10 | Univ Oxford Innovation Ltd | High-grade serous ovarian carcinoma (HGSOC) |
| CN110452982B (en) * | 2019-05-08 | 2024-07-26 | 中山大学孙逸仙纪念医院 | Breast cancer circulating tumor cell miRNA and EMT marker combined detection kit and application thereof |
| CN110551819B (en) * | 2019-08-23 | 2023-05-16 | 伯克利南京医学研究有限责任公司 | Application of ovarian cancer prognosis related genes |
| CN111705060B (en) * | 2020-06-29 | 2023-07-28 | 北京大学深圳医院 | shRNA of NCAPD2 gene and application thereof |
| CN111781364B (en) * | 2020-08-25 | 2023-07-21 | 北京信诺卫康科技有限公司 | Wnt7a and HE4 combined as early ovarian cancer biomarker and kit |
| CN112289450B (en) * | 2020-12-25 | 2021-05-18 | 浙江高美生物科技有限公司 | Prediction system for prognosis survival period of intrahepatic cholangiocellular carcinoma patient |
| CN113209313A (en) * | 2021-06-25 | 2021-08-06 | 华中科技大学同济医学院附属同济医院 | Application of Tgfbr2 in preparation of ovarian function protection medicine |
| CN113774135B (en) * | 2021-09-17 | 2024-03-08 | 广东省人民医院 | Group of markers for predicting prognosis of high-grade serous ovarian cancer and application thereof |
| CN114381529B (en) * | 2022-03-16 | 2022-06-10 | 上海晟燃生物科技有限公司 | Application of ACTR10 and CA125 combination in ovarian cancer detection and kit |
| CN117594243B (en) * | 2023-10-13 | 2024-05-14 | 太原理工大学 | Ovarian cancer prognosis prediction method based on cross-modal view association discovery network |
| CN118006766B (en) * | 2024-04-09 | 2024-06-28 | 鄂尔多斯市中心医院（内蒙古自治区超声影像研究所） | Application of POLA2 in diagnosis of metabolic syndrome |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100310583A1 (en) * | 2007-01-31 | 2010-12-09 | Immune Disease Institute | Let-7 microrna and mimetics thereof as therapeutics for cancer |
| US8030060B2 (en) * | 2007-03-22 | 2011-10-04 | West Virginia University | Gene signature for diagnosis and prognosis of breast cancer and ovarian cancer |
| US20120015049A1 (en) * | 2009-01-14 | 2012-01-19 | Lin Zhang | Microrna biomarker in cancer |
| US9953129B2 (en) * | 2011-09-23 | 2018-04-24 | Agency For Science, Technology And Research | Patient stratification and determining clinical outcome for cancer patients |
-
2013
- 2013-10-11 SG SG11201502778TA patent/SG11201502778TA/en unknown
- 2013-10-11 SG SG10201703022SA patent/SG10201703022SA/en unknown
- 2013-10-11 CN CN201380065419.9A patent/CN104854247A/en active Pending
- 2013-10-11 US US14/435,155 patent/US20150267259A1/en not_active Abandoned
- 2013-10-11 WO PCT/SG2013/000436 patent/WO2014058394A1/en active Application Filing
- 2013-10-11 EP EP13845996.1A patent/EP2906724A4/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP2906724A1 (en) | 2015-08-19 |
| US20150267259A1 (en) | 2015-09-24 |
| SG11201502778TA (en) | 2015-05-28 |
| CN104854247A (en) | 2015-08-19 |
| WO2014058394A1 (en) | 2014-04-17 |
| EP2906724A4 (en) | 2016-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201703022SA (en) | Method of prognosis and stratification of ovarian cancer | |
| IL276488B (en) | Method of predicting breast cancer prognosis | |
| HK1206431A1 (en) | Method for the prognosis and treatment of cancer metastasis | |
| HK1219763A1 (en) | Compositions and methods for cancer prognosis | |
| HK1213771A1 (en) | Methods of treating cancer | |
| HK1212256A1 (en) | Anti-mcam antibodies and associated methods of use -mcam | |
| IL237791A0 (en) | Method of treating cancer | |
| HK1204302A1 (en) | Compositions and methods for cancer immunotherapy | |
| EP2922861A4 (en) | Biomarker compositions and methods | |
| EP2823306A4 (en) | Biomarker compositions and methods | |
| SG11201503893RA (en) | Method of treating cancer | |
| HK1197273A1 (en) | Methods and materials related to ovarian cancer | |
| HK1206414A1 (en) | Biomarkers for gastric cancer and uses thereof | |
| HK1259001A1 (en) | Methods of prognosis and diagnosis of cancer | |
| HK1215193A1 (en) | Methods of treating ovarian cancer with dll4 antagonists dll4 | |
| EP2895206A4 (en) | Method of treating cancer | |
| HK1205558A1 (en) | Methods and biomarkers for detection and prognosis of cervical cancer | |
| GB2510539B (en) | Biomarkers of cancer | |
| HK1200502A1 (en) | Method for determining prognosis of prostate cancer in a subject | |
| EP2812694A4 (en) | Assays and methods for the diagnosis of ovarian cancer | |
| EP2709730A4 (en) | Treatment and prognosis of cancer | |
| EP2916200A4 (en) | Semi-compact keyboard and method therefor | |
| ZA201503833B (en) | Method of hemoglobin-f determination | |
| GB201222952D0 (en) | Treatent of cancer |